Gastroenterology
Volume 129, Issue 3 , Pages 1005-1018, September 2005

Differential Regulation of Gastric Tumor Growth by Cytokines That Signal Exclusively Through the Coreceptor gp130

  • Meegan Howlett

      Affiliations

    • Department of Medicine, University of Melbourne at Western Hospital, Footscray, Australia
    • M.H. and L.M.J. contributed equally to this work.
  • ,
  • Louise M. Judd

      Affiliations

    • Department of Medicine, University of Melbourne at Western Hospital, Footscray, Australia
    • M.H. and L.M.J. contributed equally to this work.
  • ,
  • Brendan Jenkins

      Affiliations

    • Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia
    • Ludwig Institute of Cancer Research, Parkville, Australia
  • ,
  • Nicole L. La Gruta

      Affiliations

    • Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia
  • ,
  • Dianne Grail

      Affiliations

    • Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia
    • Ludwig Institute of Cancer Research, Parkville, Australia
  • ,
  • Matthias Ernst

      Affiliations

    • Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia
    • Ludwig Institute of Cancer Research, Parkville, Australia
  • ,
  • Andrew S. Giraud

      Affiliations

    • Department of Medicine, University of Melbourne at Western Hospital, Footscray, Australia
    • Corresponding Author InformationAddress requests for reprints to: Andrew S. Giraud, PhD, Department of Medicine, University of Melbourne at Western Hospital, Footscray, 3011, Australia; fax: (61) 3-9318-1157.

Received 10 November 2004; accepted 9 June 2005.

Background & Aims: We have shown that mice with a mutation in gp130 (gp130757F/F), the signal transducing receptor for interleukin (IL)-6 family cytokines, have chronic gastric inflammation and develop distal stomach tumors associated with deregulated phosphorylated STAT3 expression. This model recapitulates many characteristics of intestinal-type gastric cancer in humans. Methods: To evaluate the role of IL-6 and IL-11 as ligands regulating tumor growth and submucosal invasion, we compared tumor characteristics of gp130757F/F mice with gp130757F/F mice lacking IL-6 or mature T and B cells. Results: As a result of the gp130757F/F mutation, expression of IL-6 and IL-11 was greatly up-regulated concomitant with activation of STAT3 and development of tumors. However, the lack of IL-6 or T and B cells did not impact on tumor growth. While IL-6 did not regulate tumor growth or tumor vascularization, gp130757F/F/IL-6−/− mice showed ∼10–20—fold more submucosal tumor invasion, reduced mononuclear inflammatory cell infiltrate, and greater IL-11 and matrix metalloproteinase (MMP)-13 and MMP-9 synthesis than gp130757F/F mice. Expression of MMP-13 was largely restricted to tumor-associated stroma, but MMP-9 was also expressed in polymorphonuclear cells and a subset of epithelial cells. In addition, treatment with recombinant IL-11 stimulated expression of MMP-13 and MMP-9 in stomachs of wild-type mice. Conclusions: Increased submucosal invasion in gp130757F/F/IL-6−/− mice could not be explained by increased vascularization or reduced immunosurveillance but was most likely facilitated by augmented metalloproteinase activity driven by elevated IL-11 levels.

Abbreviations used in this paper:  ECM, extracellular matrix , ERK, extracellular signal–regulated kinase , GAPDH, glyceraldehyde-3-phosphate dehydrogenase , IL, interleukin , MMP, matrix metalloproteinase , NK, natural killer , PCR, polymerase chain reaction , PMN, polymorphonuclear , pYSTAT3, phosphorylated STAT3 , TIMP, tissue inhibitor of matrix metalloproteinase

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0016-5085(05)01356-9

doi:10.1053/j.gastro.2005.06.068

Gastroenterology
Volume 129, Issue 3 , Pages 1005-1018, September 2005